Clinical Trials Browser

Phase 1 × crenolanib × Other hematologic neoplasm × Clear all

NCT02270788 2017-10-03

Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute